ライフサイエンスコーパス: enzyme inhibition

1 s determined by alpha-amylase and tyrosinase enzyme inhibition.

2 sembly and suggest additional approaches for enzyme inhibition.

3 ith androgenic activity and neurotransmitter enzyme inhibition.

4 f bacterial growth, receptor antagonism, and enzyme inhibition.

5 re all ameliorated by angiotensin-converting enzyme inhibition.

6 rent beta-blockade or angiotensin-converting enzyme inhibition.

7 the mucosal alpha-glucosidases by selective enzyme inhibition.

8 of substrate hydrolysis and the kinetics of enzyme inhibition.

9 oreover, it was not competitive with ATP for enzyme inhibition.

10 ts, and catalysts, decreasing noncompetitive enzyme inhibition.

11 toxicity biosensors as tools to investigate enzyme inhibition.

12 rticular benefit from angiotensin-converting enzyme inhibition.

13 th clogP values of <1.25 were ineffective at enzyme inhibition.

14 mediate significantly reduces the potency of enzyme inhibition.

15 (CO) or nitric oxide can bind, resulting in enzyme inhibition.

16 he cAMP-dependent pathway, leading to strong enzyme inhibition.

17 ilarity indices analysis (CoMSIA) models for enzyme inhibition.

18 n studies rule out the possibility of direct enzyme inhibition.

19 in TFKs, can be developed for use in in vivo enzyme inhibition.

20 butions of specific BMCC-Cys adducts to PP2A enzyme inhibition.

21 n the k(2)/K(s) parameter and in more facile enzyme inhibition.

22 al proteasome ATPase, S-nitrosylation caused enzyme inhibition.

23 tencies do not always correlate with the RAF enzyme inhibition.

24 sphoglycerate mutase 1 (PGAM1), resulting in enzyme inhibition.

25 tes of AP/enzyme generation and steady state enzyme inhibition.

26 rostatic interactions, resulting in complete enzyme inhibition.

27 calculation, were tested experimentally for enzyme inhibition.

28 ating cellular activity and reversibility of enzyme inhibition.

29 nding domain of the Ca-ATPase that modulates enzyme inhibition.

30 that inhibition was not the result of direct enzyme inhibition.

31 extend well beyond those of cycloxoxygenase enzyme inhibition.

32 fit from additional, accurate information on enzyme inhibition.

33 a Isothermal Titration Calorimetry (ITC) and enzyme inhibition.

34 f hBCATm with sulfhydryl reagents results in enzyme inhibition.

35 bisubstrate system could be used to maximize enzyme inhibition.

36 single experiment and can be used to measure enzyme inhibition.

37 ria during fixed dose angiotensin-converting enzyme inhibition.

38 ncreased 5-fold after angiotensin-converting enzyme inhibition.

39 n the low micromolar range paralleling their enzyme inhibition.

40 nt binding and cooperativity with respect to enzyme inhibition.

41 gested a role for the mutated amino acids in enzyme inhibition.

42 id was designed, synthesized, and tested for enzyme inhibition.

43 genase (GAPDH) by S-nitrosylation and caused enzyme inhibition.

44 s solubility without significantly affecting enzyme inhibition.

45 el for rational drug design through specific enzyme inhibition.

46 546, in a cAMP-dependent manner, leading to enzyme inhibition.

47 ronel-P450 complex is not a prerequisite for enzyme inhibition.

48 ally expressed genes mapped to mitochondrial enzyme inhibition.

49 t 9 years (2006-2014) on biosensors based on enzyme inhibition.

50 n the lipid membrane, resulting in efficient enzyme inhibition.

51 y using a biochemical assay to study Topo II enzyme inhibition.

52 rs that do not need metabolic conversion for enzyme inhibition.

53 ssays for COX-1 and COX-2 activity to assess enzyme inhibition.

54 more effectively than angiotensin-converting enzyme inhibition.

55 is essential for both DNA intercalation and enzyme inhibition.

56 ble for their rapid and initially reversible enzyme inhibition.

57 erization alleviated concentration-dependent enzyme inhibition.

58 xamates to MPO correlated with the degree of enzyme inhibition.

59 this behavior and the targeted irreversible enzyme inhibition, 3 reversed cold allodynia in the chro

60 2-pyridyl)urea, provided sufficiently potent enzyme inhibition (32 muM) to prompt further analogue wo

61 ion of ERK leads to eNOS phosphorylation and enzyme inhibition, a process influenced by the reversibl

62 to determine whether angiotensin-converting enzyme inhibition (ACE-I) (i.e., quinapril) prevents tra

63 We hypothesized that angiotensin-converting enzyme inhibition (ACE-I) during left ventricular assist

64 In diabetic patients, angiotensin-converting enzyme inhibition (ACEI) restores the effect of glycine

65 Our data therefore suggest a novel enzyme inhibition/activation mechanism where a disulfide

66 ected and assayed, and 15 were found to have enzyme inhibition activity at micromolar concentration.

67 ed and assayed, and seven were found to have enzyme inhibition activity at micromolar concentrations.

68 g of resistance mutation coupled with potent enzyme inhibition activity confirmed the molecular targe

69 itors are not prone to widespread off-target enzyme inhibition activity.

70 to form lipophilic analogs that retain their enzyme-inhibition activity and are also effective in vit

71 ctivated Raw 264.7 cells without showing any enzyme-inhibition activity.

72 ped a method to measure the level of MetAP-2 enzyme inhibition after exposure to PPI-2458 and demonst

73 ecognition correlated well with the rates of enzyme inhibition, aging, and oxime-induced reactivation

74 tioxidant therapy and angiotensin-converting enzyme inhibition alleviated the CRF-induced oxidative s

75 n more effective than angiotensin-converting enzyme inhibition alone in heart failure with reduced ej

76 The most relevant effect on enzyme inhibition (alpha-amylase: IC(50)-42.34 ug/mL; al

77 positively cooperative manner, resulting in enzyme inhibition (AMP or ADP) or activation (ATP).

78 Kinetic enzyme inhibition analysis produced 50% inhibitory conce

79 ially toxic drug-drug interactions involving enzyme inhibition and acceleration.

80 ach, several cycles of externally controlled enzyme inhibition and activation are successfully demons

81 s, compartmentalization minimizes inevitable enzyme inhibition and alleviates constraints that self-i

82 Angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blo

83 folates that exhibit inconsistencies between enzyme inhibition and antifungal properties.

84 Angiotensin-converting enzyme inhibition and antiplatelet therapy with aspirin

85 cterial cidality can be achieved with potent enzyme inhibition and appropriate physicochemical proper

86 d efficacy for use of angiotensin-converting enzyme inhibition and beta-blockers in dilated cardiomyo

87 In this study, enzyme inhibition and binding of HSPDE4B2B by (R, R)-(+/

88 bition and FPPS (human and Leishmania major) enzyme inhibition and by the fact that a T. gondii strai

89 additional insight into the role of water in enzyme inhibition and catalysis.

90 A good correlation was observed between enzyme inhibition and cellular assays.

91 as multivalent scaffolds for drug delivery, enzyme inhibition and for vaccine development, glycan fu

92 lop PDK-1 inhibitors with greater potency in enzyme inhibition and growth inhibition.

93 ino-terminal acetylation of PT-100 abrogated enzyme inhibition and hematopoietic stimulation.

94 In addition, details of enzyme inhibition and in vivo activity against Saccharom

95 mannoside hydrolysis informs strategies for enzyme inhibition and inspires solutions to mannoside sy

96 The best inhibitors have enzyme inhibition and MIC values near or below that of t

97 al screening techniques and characterized by enzyme inhibition and NMR and Biacore binding experiment

98 are from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors

99 but also of more destructive ones including enzyme inhibition and oxidative damage.

100 In addition, we tested enzyme inhibition and performed theoretical calculations

101 ount of enzyme for simultaneous detection of enzyme inhibition and phosphorylation in biological flui

102 lipoic acid closely paralleled the degree of enzyme inhibition and reactivation.

103 sulting lead compound 24 exhibited excellent enzyme inhibition and selectivity for CDPK1 and potently

104 flexibility at the active site that explains enzyme inhibition and structure-activity relationships f

105 he ethane-1,2-dione moiety was essential for enzyme inhibition and that potency was dependent on the

106 nsecutive months with angiotensin-converting enzyme inhibition and/or angiotensin-receptor blocker (A

107 stituent was found to be critical for potent enzyme inhibition, and an N-(2-methoxyethyl)carboxamide

108 pid-lowering therapy, angiotensin-converting enzyme inhibition, and antiplatelet drugs significantly

109 dging to a key asparagine residue, improving enzyme inhibition, and leading to measurable antibacteri

110 Angiotensin-converting enzyme inhibition/angiotensin-receptor blocker therapy i

111 Data are presented for enzyme inhibition, antibacterial activity, and in vivo e

112 luding antimicrobial, angiotensin-converting enzyme inhibition, antioxidant, opioid, and immunomodula

113 eriments in which the modes of mitochondrial enzyme inhibition are far from those observed in real li

114 classification results for human and murine enzyme inhibition are found using kNN.

115 Studies of metabolic enzyme inhibition are necessary in drug development and

116 se devices; particularly biosensors based on enzyme inhibition are useful analytical tools for fast s

117 adioligand at the same concentrations as for enzyme inhibition, arylsulfonamides and benzodiazepines

118 Dihydro-4-pyridone 3 possessed improved enzyme inhibition as measured by its kinact value agains

119 ibited low nanomolar potency in the in vitro enzyme inhibition assay (IC(50) = 18 nM) and submicromol

120 Enzyme inhibition assay in vitro and in vivo showed that

121 The efficacy for an enzyme inhibition assay was characterized by deriving an

122 for generating a dose-response curve for an enzyme inhibition assay.

123 tested at a concentration of 30 microM in an enzyme inhibition assay.

124 resonance (SPR) based assay combined with an enzyme inhibition assay.

125 nhibitor that will be readily detected by an enzyme inhibition assay?

126 ing surface plasmon resonance and functional enzyme inhibition assays afforded micromolar inhibitors.

127 Enzyme inhibition assays against rat liver DHFR, Pneumoc

128 ulness of screening resistance markers in NA enzyme inhibition assays and animal models of AIV infect

129 (Y102F)DHFR, were created and evaluated with enzyme inhibition assays and crystal structures.

130 Two pivotal enzyme inhibition assays prove that the compounds are tr

131 Enzyme inhibition assays show that three of the four hig

132 g fits the active site poorly and results of enzyme inhibition assays using TLM analogues are wholly

133 ering RNA technology, reporter activity, and enzyme inhibition assays were exploited to define the me

134 Pharmacokinetic and in vitro enzyme inhibition assays were performed to characterize

135 were obtained in rats; (2) multiple in vitro enzyme inhibition assays were performed to characterize

136 Fluorimetric enzyme inhibition assays were used to determine the inhi

137 Enzyme inhibition assays with phenylethyl-beta-D-thiogal

138 resonance-based screening complemented with enzyme inhibition assays, we discovered an N-aryl mercap

139 Using enzyme inhibition assays, we show that lysobactin forms

140 hich were demonstrated to be compatible with enzyme inhibition assays.

141 tly bright to enable quantitative enzyme and enzyme inhibition assays.

142 of the deformylase, pH profile studies, and enzyme inhibition assays.

143 Enzyme-inhibition assays using a GST-SCCA2 fusion protei

144 d moderate hCOX-1 activity (19.5% and 28% of enzyme inhibition at 25 muM respectively).

145 3 and H4 acetylation and histone deacetylase enzyme inhibition at concentrations corresponding to the

146 Mg(2+) binding is likely responsible for the enzyme inhibition at high concentrations of the cation.

147 ance CYP46A1 activity, with reduced unwanted enzyme inhibition at higher concentrations.

148 results, reveals the molecular mechanism of enzyme inhibition at the highly conservative substrate-r

149 or dATP in real time, allowing detection of enzyme inhibition based on differences in ATP/dATP consu

150 This report describes an enzyme inhibition-based holographic sensor as a potentia

151 nd there was no significant resin fouling or enzyme inhibition between cycles.

152 classes of pesticides by combining different enzyme-inhibition biosensors.

153 The compounds showed pan-erbB enzyme inhibition but were on average about 10-fold more

154 tages of disease, capable not only of target enzyme inhibition, but also crossreactive with chemical

155 protein disulfide formed led to a permanent enzyme inhibition, but upon dithiothreitol addition a fu

156 ition revealed that the stoichiometry of the enzyme inhibition by 3H4PTT is 1:1.

157 y, potentially allowing assessment of direct enzyme inhibition by almost any compound.

158 es COX activity; moreover, some NSAIDs cause enzyme inhibition by binding only one monomer.

159 Enzyme inhibition by CPHM was found to be highly specifi

160 SDS--PAGE and protection of 4-OHEN-mediated enzyme inhibition by free radical scavengers.

161 ubunit as a domain that mediates binding and enzyme inhibition by I-1.

162 Enzyme inhibition by OA-NO2 is not reversed by thiol rea

163 The assays were employed to measure enzyme inhibition by small molecules and activity in cel

164 confirming that a high level of photoinduced enzyme inhibition can be obtained using this method.

165 Finally, angiotensin-converting enzyme inhibition (captopril) normalized blood pressure

166 Cyanide interference on the enzyme inhibition caused 43.25% error in the calibration

167 emodynamic effects of angiotensin-converting enzyme inhibition (CEI).

168 The enzyme inhibition concurred with S-glutathionylation of

169 e, Cpd 5 caused time-dependent, irreversible enzyme inhibition, consistent with arylation of the cata

170 rythrocytes, a clear correlation between the enzyme inhibition constants and P. falciparum inhibition

171 techniques: TdF or TdCD, and also consistent enzyme inhibition constants reported in the literature.

172 ed hydrolysis of the drug and the potency of enzyme inhibition correlated with the clogP of the molec

173 oblematic functional groups, suggesting that enzyme inhibition could be the result of undesirable sid

174 ite-proximal cysteine and that the resulting enzyme inhibition creates a negative feedback mechanism

175 athway catalysis, off-pathway catalysis, and enzyme inhibition, crystal structures of Escherichia col

176 The synthesis and enzyme inhibition data for a series of thiadiazole urea

177 The synthesis and enzyme inhibition data for a series of thiazine- and thi

178 how cell activity can be predicted based on enzyme inhibition data, and using X-ray diffraction, sol

179 represent a general way to predict cell from enzyme inhibition data, with in three cases, R(2) values

180 se a rapid increase in Abeta production when enzyme inhibition discontinues.

181 Enzyme inhibition due to the reversible binding of react

182 thematical model for stepwise "slow-binding" enzyme inhibition (E+Iright harpoon over left harpoonEIr

183 Enzyme inhibition experiments showed that the activity i

184 is manner correlate with previously reported enzyme inhibition experiments, as well as computational

185 Based on "growth-rescue" and enzyme-inhibition experiments, geranylgeranyl diphosphat

186 nd inexpensive quantification of OP-BChE and enzyme inhibition for biomonitoring of OP and nerve agen

187 Enzymes inhibition gives results which correlate with po

188 r the effect of rice phenolics on carbolytic enzyme inhibition, glucose uptake, hepatic glucose homeo

189 igin, display antidiabetic properties due to enzyme inhibition (glycogen phosphorylase, protein tyros

190 or for coronary heart disease and converting enzyme inhibition has been demonstrated to decrease the

191 Although angiotensin-converting enzyme inhibition has been shown to slow progression of

192 Although this combination of enzyme inhibition has shown synergy in intestinal polyp

193 working of anti-inflammatory agents through enzyme inhibition, herein, COX-2 was provided with an al

194 fication of a lead series with submicromolar enzyme inhibition, high ligand efficiency, and a novel s

195 -eight compounds were identified with PfNDH2 enzyme inhibition IC(50) values ranging from 100 nM to 4

196 - f][1,2,4]triazine lead 2a displayed potent enzyme inhibition (IC 50 60 nM) and was active in a cell

197 The dissociation constants (K(d)) and enzyme inhibition (IC(50)) of fragment hits were measure

198 ors was prepared and shown to possess potent enzyme inhibition (IC50 values <50 nM), antibacterial ef

199 this SERS approach has utility in monitoring enzyme inhibition illustrating additional medical signif

200 ated Akt suppression mimicked the effects of enzyme inhibition in cultured cells.

201 receptor blockade or angiotensin-converting enzyme inhibition in DNP.

202 iopsies that demonstrated at least 50% FTase enzyme inhibition in the primary tumor (median, 100%; ra

203 The results suggest a novel mechanism of enzyme inhibition in which the -1 nt at the gyrase-DNA g

204 itive HFLS-RA and HUVEC is linked to MetAP-2 enzyme inhibition, in a dose-dependent fashion.

205 pal structural protein in caveolae, leads to enzyme inhibition, in a reversible process modulated by

206 Interactions involving enzyme inhibition include the increase in plasma concent

207 nd reduction of acute inflammation via Cox-2 enzyme inhibition, increased cyclobutane pyrimidine dime

208 nts provided evidence of farnesyltransferase enzyme inhibition, interference with farnesyltransferase

209 Unsustained enzyme inhibition is a barrier to targeted therapy for c

210 e structural basis for the species selective enzyme inhibition is explained by the variable amino aci

211 suggest that the primary cause of metabolic enzyme inhibition is not the evolution of regulatory met

212 At higher concentrations of Tl+, enzyme inhibition is observed with an apparent KI of 180

213 Enzyme inhibition is often driven by essential metabolit

214 ane-bound PI3Kalpha molecule, but this minor enzyme inhibition is overwhelmed by the marked enhanceme

215 (d) Enzyme inhibition is rapid and irreversible and precedes

216 ed progenitor cells and demonstrate that Car enzyme inhibition is sufficient to prevent mouse mast ce

217 splayed the most promising combination of 3C enzyme inhibition (k(obs)/[I] 170 000-223 000 M(-1) s(-1

218 Enzyme inhibition kinetic analysis was performed using h

219 Moreover, enzyme inhibition kinetics and photoaffinity probe displ

220 sm and also to evaluate the compatibility of enzyme inhibition kinetics for calculating the inhibitor

221 Enzyme inhibition kinetics were studied using a low-mole

222 lent modification of Cys181 is provided from enzyme inhibition kinetics, mass spectrometry, protein c

223 nalectomy and 5alpha-reductase type-1/type-2 enzyme inhibition, known to reduce neuroactive steroids,

224 on of low-dose CsA and endothelin-converting enzyme inhibition may prove useful to improve long-term

225 were investigated using stopped-flow kinetic enzyme-inhibition measurements, native mass spectrometry

226 at the adduct binds to WT InhA by a two-step enzyme inhibition mechanism, with initial, weak binding

227 n mechanisms were borrowed from steady-state enzyme inhibition mechanisms.

228 yeast estrogen screen), and neurotransmitter enzyme inhibition (monoamine oxidase and glutamic acid d

229 experimentation and generated a genome-scale enzyme-inhibition network.

230 Neither angiotensin-converting enzyme inhibition nor mineralocorticoid receptor blockad

231 The nonparallel human/mouse enzyme inhibition observations were extended to a cell-c

232 CYP450 enzyme inhibition observed with 11 was reduced with 38.

233 MLN4924 is a mechanism-based inhibitor, with enzyme inhibition occurring through the formation of a t

234 ts demonstrate a relationship between target enzyme inhibition of histone deacetylase, histone H3 and

235 This review focuses on the synthesis and enzyme inhibitions of a few selected (synthetic or non-n

236 active site inhibitors designed for specific enzymes, inhibition of cell signalling molecules and tra

237 system through either angiotensin converting enzyme inhibition or angiotensin II type 1 receptor bloc

238 unds in clementine juice provoking metabolic enzyme inhibition or induction.

239 actions with the target protein-for example, enzyme inhibition or ligand blocking.

240 ined in complex fluids due to issues such as enzyme inhibition or signal interference.

241 ention of Events With Angiotensin-Converting Enzyme Inhibition (PEACE) trial, a randomized placebo-co

242 ention of Events with Angiotensin Converting Enzyme Inhibition (PEACE) Trial, we tested the hypothesi

243 of applications including use in catalysis, enzyme inhibition, photochemistry, molecular logic and m

244 l use of a NIMS chip as a multiple screening enzyme inhibition platform was explored.

245 APMA activation affects natural enzyme inhibition, possibly by chemical modification of

246 II production through angiotensin-converting enzyme inhibition prevented glucose-mediated increased T

247 The CA enzyme inhibition profile as well as the protein X-ray c

248 The CA enzyme inhibition profile for all compounds was determin

249 n ITC method for the detailed description of enzyme inhibition, proving the power of this approach in

250 ype II spectral changes, and IC50 values for enzyme inhibition ranged from 0.1 to 2.4 microM, followi

251 Carvedilol added to angiotensin-converting enzyme inhibition reduces hospitalization risk as well a

252 entiation may be a consequence of microsomal enzyme inhibition reducing the metabolism of cytotoxics

253 to Top1 and TDP1 was used to rationalize the enzyme inhibition results and structure-activity relatio

254 Quantitative modeling of human enzyme inhibition results in a nonlinear, five-descripto

255 ex; CoMFA and CoMSIA) methods to analyze the enzyme inhibition results.

256 d with responses with angiotensin-converting enzyme inhibition (rise in RPF approximately 95 mL x min

257 It is recognized that high-throughput enzyme inhibition screens often return nonspecific inhib

258 ral classes were comparatively evaluated for enzyme inhibition, selectivity, and drug-like properties

259 It appears that enzyme inhibition should be considered, more seriously,

260 Described herein are the synthesis, enzyme inhibition structure-activity relationships (SARs

261 ore, they may be of future use in studies of enzyme inhibition, structure, mechanism, and function.

262 Enzyme inhibition studies and mutational analyses demons

263 of kinesin spindle protein (KSP) followed by enzyme inhibition studies and temperature-dependent circ

264 Furthermore, enzyme inhibition studies demonstrated that CMP could in

265 Enzyme inhibition studies indicate that indenoisoquinoli

266 Enzyme inhibition studies indicate that only one of the

267 Competitive binding and enzyme inhibition studies showed that photoaffinity labe

268 es, synthesized them, and conducted in vitro enzyme inhibition studies with the three isozymes of NOS

269 Herein, we report the synthesis, enzyme inhibition studies, and cellular antiviral data f

270 ydralazine on DNMT was tested in vitro using enzyme inhibition studies, and in vivo by measuring mess

271 n agreement with the Ki values determined by enzyme inhibition studies.

272 The patterns of mutant PDE5-conePDE6 enzyme inhibition suggest the interaction between the Pg

273 ied in both vegetable and soil samples by an enzyme inhibition technique.

274 s and flavonoids shall be evaluated prior to enzyme inhibition testing in order to ensure consistent

275 adicting effects with quantitative models of enzyme inhibition that account for fitness costs and the

276 Within 24h of enzyme inhibition, there was substantial and dose-depend

277 Translating enzyme inhibition to bacterial cidality by targeting the

278 stand these processes and correlate in vitro enzyme inhibition to whole cell activity, a better assay

279 a number of inhibitors demonstrated in vitro enzyme inhibition, two compounds in particular showed ex

280 ate equation for the time course of covalent enzyme inhibition under the conditions where the substra

281 Promiscuous binders achieve enzyme inhibition using a nonspecific aggregation-type b

282 3; 95% CI 0.43-0.92), angiotensin-converting enzyme inhibition vs placebo (RR 0.60; 95% CI 0.41-0.86)

283 The degree of enzyme inhibition was abated in a reduced oxygen environ

284 The degree of enzyme inhibition was abated in a reduced oxygen environ

285 Brain enzyme inhibition was concentration-dependent, with a 90

286 Enzyme inhibition was dependent on the presence of subst

287 ity of botanicals using microfluidics, where enzyme inhibition was employed to indicate the drug's ac

288 aria parasites, and the structural basis for enzyme inhibition was explored through in silico structu

289 On the basis of structural insights, enzyme inhibition was increased 40-fold through hybridiz

290 Enzyme inhibition was indicated by a decrease in product

291 was not prevented by thiols, suggesting that enzyme inhibition was not occurring via NO reaction with

292 COX-2 enzyme inhibition was statistically equivalent between f

293 rimarily treated with angiotensin-converting enzyme inhibition, was equal in the fish oil and placebo

294 itutions of charged residues not involved in enzyme inhibition, was not taken up at all.

295 of different concentrations, the degrees of enzyme inhibition were found to be 40 and 85%, consisten

296 Structure-activity relationships for enzyme inhibition were identified for some series of TLM

297 FadD33 acetylation leads to enzyme inhibition, which can be reversed by the NAD(+)-d

298 efore, our data suggest that measurements of enzyme inhibition with mutant proteases may be poorly pr

299 In vivo heme oxygenase enzyme inhibition with tin protoporphyrin IX in common b

300 ently informative about what AA metabolizing enzyme inhibition would be most growth inhibitory, the f